The ”la Caixa” Foundation has awarded funding to 80 new biomedical and health projects led by research centres, universities and…
NOTICIAS
Nicolás Anselmino, a postdoctoral researcher in the Prostate Cancer Group at the Vall d’Hebron Institute of Oncology (VHIO), has received…
On 6 and 7 October, the Vall d’Hebron Institute of Oncology (VHIO) hosted the kick-off meeting of the GLIOLIFE-AECC project….
The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors. A study…
Developed in conjunction with The Lancet Oncology Commission on Cancer Genomics and Precision Oncology, with the contributions of over 150…
The initiative is also made possible thanks to the involvement of nearly one hundred volunteers who, over several months, work…
A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy Cancer neoantigens and neoantigen-specific T…
In the two decades since its official establishment in 2006, the Vall d’Hebron Institute of Oncology (VHIO) has established itself…
An international study led by VHIO within the ENIGMA consortium has analysed 166 variants in and around exon 18 of…
First results from the multicenter FUSOMAP project, led by VHIO, support the potential use of Fusobacterium as a prognostic and…
